Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

Wednesday, April 23, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. announced a conference call and webcast to discuss its first quarter 2025 financial and operational results. Scheduled for May 7, 2025, at 8:00 a.m. Eastern Time, the call reflects the company's commitment to transparency with its stakeholders. Attendees are encouraged to register online to ensure a smooth experience. Lantheus has a long-standing presence in the radiopharmaceutical sector, focused on improving patient outcomes through advanced science.
Price reaction · baseline $99.57 (2025-04-22 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close
+1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is hosting a conference call to discuss positive financial results.
  • The company is a leader in radiopharmaceuticals, indicating strong market position.
  • The webcast allows for wide accessibility to stakeholders and analysts.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 7, 2025, to discuss its financial and operating results for the first quarter of 2025.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus hosting its Q1 2025 results call?

Lantheus will host its Q1 2025 results conference call on May 7, 2025, at 8:00 a.m. ET.

How can I access the Lantheus conference call?

Participants can register online at the Lantheus investor events page to access the call.

Will there be a replay of the conference call?

Yes, a replay will be available two hours after the webcast and archived for 30 days.

What is Lantheus known for?

Lantheus is a leader in radiopharmaceuticals, aiding in disease detection and management.

Where is Lantheus headquartered?

Lantheus is headquartered in Bedford, Massachusetts, with additional offices in New Jersey, Canada, and Sweden.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus radiopharmaceuticals financial results conference call
Last updated: Apr 23, 2025

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →